Safety and efficacy of talacotuzumab plus decitabine or decitabine alone in patients with acute myeloid leukemia not eligible for chemotherapy: results from a multicenter, randomized, phase 2/3 study
| Image |  |
|---|---|
| Description | scientific article published on 16 March 2020 |
| Author/s |
author: Pau Montesinos Agnieszka Wierzbowska Daniel A Pollyea Uwe Platzbecker Sergio Giralt |
| Publication date | March 16, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |